Heparin

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Heparin

Abstract

Citations

Contemporary use of and future roles for heparin in antithrombotic therapy

Treatment of thromboembolic complications in patients with brain tumors

Novel Antithrombotic Strategies for the Treatment of Coronary Artery Thrombosis: A Critical Appraisal

Improving the Efficacy and Stability of Coronary Reperfusion Following Thrombolysis: Exploring the Thrombin Hypothesis

Intravenous heparin dosing: patterns and variations in internists' practices

Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism

New method to predict patients' intravenous heparin dose requirements

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group

Prevention of venous thromboembolism after major abdominal surgery

Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study

Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians

Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis

Treatment of venous thromboembolism

Activated partial thromboplastin time (aPTT) monitoring to achieve therapeutic anticoagulation before and after introducing a nomogram for adjunctive heparin treatment with thrombolytic therapy for acute myocardial infarction

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial

Management of the anticoagulated patient for ophthalmic surgery

Utility of a weight-based heparin nomogram for patients with acute coronary syndromes

Anticoagulation therapy in patients with venous thromboembolic disease

Heparin

Clinical problem-solving. Some familiar trade-offs

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

Venous thromboembolism during pregnancy

A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes

Management of venous thromboembolism

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

Unilateral extremity swelling in female patients with cancer

An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit

Deep venous thrombosis

Venous thromboembolism during pregnancy: a current review of diagnosis and management

Antithrombotic therapy in children

Pediatric sinovenous thrombosis

Review of the initiation of anticoagulant therapy

Is a standard regime for anticoagulation with heparin in unstable angina adequate?

Clinical considerations of heparinization

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

Early reactivation of ischaemia after abrupt discontinuation of heparin in acute myocardial infarction

Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism

Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.

Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009)

An institution-specific heparin titration nomogram: development, validation, and assessment of compliance

Current management of acute symptomatic deep vein thrombosis

Related Concepts

Related Feeds

Blood Clotting Disorders

Related Papers

Audit of control of heparin treatment

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

Appropriate use of heparin. Empiric vs nomogram-based dosing

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time